Table 3:
Independent Predictors of Women Receiving Inpatient Immediate Postpartum Long Acting Reversible Contraception (IPP LARC) or Postpartum Tubal Ligation (PPTL) versus Neither
| Unadjusted OR (95%CI) | Adjusted OR (95%CI) | |
|---|---|---|
| Age, years | ||
| 18–29 | 0.42(0.40–0.43) | 0.32 (0.31–0.33) |
| 30–34 | 0.66(0.62–0.69) | 0.61(0.59–0.63) |
| > 35* | -- | -- |
| Race | ||
| Caucasian* | -- | -- |
| African-American | 1.17(1.15–1.19) | 1.21(1.16–1.24) |
| Hispanic | 1.45(1.44–1.47) | 1.55(1.51–1.59) |
| Asian/Pacific Islander | 0.61(0.59–0.63) | 0.70(0.66-.074) |
| Native American | 1.17(1.11–1.25) | 1.32(1.17–1.51) |
| Region | ||
| North | 0.80(0.79–0.81) | 0.77(0.74–0.79) |
| MidWest | 0.81(0.80–0.83) | 0.81(0.78–0.84) |
| West | 0.84(0.83–0.85) | 0.77(0.75–0.79) |
| South* | -- | -- |
| Hospital Location | ||
| Rural | 1.36(1.34–1.39) | 1.52(1.45–1.59) |
| Urban Non-Teaching | 0.93(0.92–0.94) | 1.02 (1.01–1.05) |
| Urban Teaching* | -- | -- |
| Hospital Size | ||
| Large* | -- | -- |
| Medium | 0.96(0.95–0.97) | 0.95(0.93–0.97) |
| Small | 0.96(0.95–0.98) | 1.02 (0.99–1.05) |
| Population Density Around Hospital | ||
| Central County* | -- | |
| Fringe County | 1.18(1.11–1.25) | 1.08(1.04–1.11) |
| Large Metro County | 1.05(1.04–1.06) | 1.22(1.19–1.26) |
| Small Metro County | 1.14(1.12–1.16) | 1.36(1.31–1.42) |
| Micropolitan | 1.32(1.29–1.34) | 1.17(1.11–1.22) |
| Median Household Income | ||
| 1st Quartile | 1.37(1.36–1.39) | 1.83(1.77–1.90) |
| 2nd Quartile | 1.12(1.10–1.13) | 1.64(1.59–1.70) |
| 3rd Quartile | 0.87(0.87–0.89) | 1.34(1.29–1.38) |
| 4th Quartile * | -- | -- |
| Cesarean | 7.31(7.22–7.40) | 7.25(7.08–7.43) |
| Length of Stay per Day | 1.04(1.03–1.05) | 0.99 (0.99–1.00) |
| Pre-Existing Comorbidity | ||
| Alcohol Abuse/Dependence | 1.01 (0.95–1.06) | 0.98(0.93–1.06) |
| Drug Abuse /Dependence | 1.16(1.13–1.21) | 0.98(0.92–1.04) |
| Depression | 1.22(1.19–1.26) | 1.03(0.98–1.09) |
| Psychosis | 1.16(1.11–1.20) | 1.02(0.96–1.08) |
| Anemia | 1.22(1.21–1.25) | 1.01(0.96–1.05) |
| Coagulopathy | 1.14(1.10–1.18) | 0.99(0.93–1.06) |
| Heart Failure | 0.96(0.92–1.01) | 0.98(0.93–1.03) |
| Hypothyroidism | 1.09(1.06–1.12) | 1.00(0.96–1.05) |
| Seizure Disorder | 1.06(1.02–1.10) | 0.99(0.94–1.03) |
| Obesity | 1.58(1.56–1.61) | 1.01(0.97–1.06) |
| Chronic Lung Disease | 1.13(1.11–1.15) | 1.03(0.99–1.06) |
| Chronic Hypertension | 1.15(1.13–1.17) | 0.98(0.96–1.02) |
| Pre-gestational Diabetes | 1.28(1.25–1.31) | 1.02(0.96–1.09) |
| Delivery-Related Complications | ||
| Post-partum Hemorrhage | 0.81(0.78–0.84) | 1.05(0.98–1.12) |
| Preeclampsia | 1.14(1.13–1.17) | 0.82(0.79–0.85) |
| Eclampsia | 0.50(0.39–0.64) | 0.43(0.27–0.68) |
| Transfusion | 1.61(1.56–1.68) | 1.04(0.95–1.12) |
CI = Confidence Interval
OR = Odds Ratio
*
= referent group